BACKGROUND AND PURPOSE: Treatment-induced white matter (WM) injury in medulloblastoma survivors, as manifested by deterioration of cognitive function, is prevalent. However, no reliable imaging method exists for early detection and quantification. Our goal was to determine whether anisotropy of WM is reduced in medulloblastoma survivors and whether fractional anisotropy (FA) can be used as an index for evaluation of treatment-induced WM injury. METHODS: We evaluated nine medulloblastoma survivors treated with surgery, cranial irradiation, and chemotherapy by use of diffusion-tensor (DT) imaging and compared FA findings in selected WM sites (cerebellar hemispheres, pons, medulla oblongata, frontal periventricular WM, parietal periventricular WM, and corona radiata) with those of healthy age-matched control subjects. FA maps were compared with conventional T2-weighted images. FA was also compared with age at treatment, time interval since treatment, and deterioration of school performance. The two-tailed paired t test was used to determine statistical significance (P <.05). RESULTS: Significant reduction of FA (P <.05) was seen in all anatomic sites in the patient group compared with FA in control subjects, except in the frontal periventricular WM, even in areas with normal appearance on T2-weighted images. FA reduction ranged from 12.4-19% (mean, 16.5%). Compared with control subjects, posterior fossa and supratentorial WM FA in patients were reduced by 14.6% (SD 1.9%) and 18.4% (SD 0.55%), respectively (P =.029). Reduction of supratentorial WM FA correlated with younger age at treatment (< 5 years), longer interval since treatment (> 5 years), and deterioration of school performance. CONCLUSION: DT imaging and use of the index FA is potentially useful for early detection and monitoring of treatment-induced WM injury in children with medulloblastoma.
BACKGROUND AND PURPOSE: Treatment-induced white matter (WM) injury in medulloblastoma survivors, as manifested by deterioration of cognitive function, is prevalent. However, no reliable imaging method exists for early detection and quantification. Our goal was to determine whether anisotropy of WM is reduced in medulloblastoma survivors and whether fractional anisotropy (FA) can be used as an index for evaluation of treatment-induced WM injury. METHODS: We evaluated nine medulloblastoma survivors treated with surgery, cranial irradiation, and chemotherapy by use of diffusion-tensor (DT) imaging and compared FA findings in selected WM sites (cerebellar hemispheres, pons, medulla oblongata, frontal periventricular WM, parietal periventricular WM, and corona radiata) with those of healthy age-matched control subjects. FA maps were compared with conventional T2-weighted images. FA was also compared with age at treatment, time interval since treatment, and deterioration of school performance. The two-tailed paired t test was used to determine statistical significance (P <.05). RESULTS: Significant reduction of FA (P <.05) was seen in all anatomic sites in the patient group compared with FA in control subjects, except in the frontal periventricular WM, even in areas with normal appearance on T2-weighted images. FA reduction ranged from 12.4-19% (mean, 16.5%). Compared with control subjects, posterior fossa and supratentorial WM FA in patients were reduced by 14.6% (SD 1.9%) and 18.4% (SD 0.55%), respectively (P =.029). Reduction of supratentorial WM FA correlated with younger age at treatment (< 5 years), longer interval since treatment (> 5 years), and deterioration of school performance. CONCLUSION:DT imaging and use of the index FA is potentially useful for early detection and monitoring of treatment-induced WM injury in children with medulloblastoma.
Authors: A W Walter; R K Mulhern; A Gajjar; R L Heideman; D Reardon; R A Sanford; X Xiong; L E Kun Journal: J Clin Oncol Date: 1999-12 Impact factor: 44.544
Authors: M Jankovic; P Brouwers; M G Valsecchi; A Van Veldhuizen; J Huisman; R Kamphuis; A Kingma; W Mor; J Van Dongen-Melman; L Ferronato Journal: Lancet Date: 1994-07-23 Impact factor: 79.321
Authors: E Hoppe-Hirsch; L Brunet; F Laroussinie; G Cinalli; A Pierre-Kahn; D Rénier; C Sainte-Rose; J F Hirsch Journal: Childs Nerv Syst Date: 1995-06 Impact factor: 1.475
Authors: O Ciccarelli; D J Werring; C A Wheeler-Kingshott; G J Barker; G J Parker; A J Thompson; D H Miller Journal: Neurology Date: 2001-04-10 Impact factor: 9.910
Authors: Ali Mahta; Yan Qu; Denis Nastic; Maria Sundstrom; Ryan Y Kim; Marlon Saria; Sandro Santagata; Santosh Kesari Journal: Pathol Oncol Res Date: 2011-09-28 Impact factor: 3.201
Authors: Shawna L Palmer; Wilburn E Reddick; John O Glass; Robert Ogg; Zoltan Patay; Dana Wallace; Amar Gajjar Journal: Brain Imaging Behav Date: 2010-06 Impact factor: 3.978
Authors: Jinsoo Uh; Thomas E Merchant; Yimei Li; Xingyu Li; Noah D Sabin; Daniel J Indelicato; Robert J Ogg; Frederick A Boop; John A Jane; Chiaho Hua Journal: Int J Radiat Oncol Biol Phys Date: 2015-05-16 Impact factor: 7.038
Authors: Tara M Brinkman; Wilburn E Reddick; Joshua Luxton; John O Glass; Noah D Sabin; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Kevin R Krull Journal: Neuro Oncol Date: 2012-09 Impact factor: 12.300